Biocon informs about press release

01 Apr 2022 Evaluate

Biocon has informed that it enclosed a press release ‘Biocon Biologics' Partner Receives Positive EU CHMP Opinion for Biosimilar Human Insulin for IV Infusion’.

The above information is a part of company’s filings submitted to BSE.

Biocon Share Price

366.40 -6.25 (-1.68%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×